---
title: "Tyra Biosciences director Rehan Verjee buys $20,000 of common shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298766960.md"
description: "Tyra Biosciences director Rehan Verjee purchased 971 shares of common stock on the open market for approximately $20,000. The weighted average purchase price was $20.58 per share. Following this transaction, Verjee's direct holding increased to 971 shares."
datetime: "2026-09-11T20:31:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298766960.md)
  - [en](https://longbridge.com/en/news/298766960.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298766960.md)
generator: "portal-rs"
---

# Tyra Biosciences director Rehan Verjee buys $20,000 of common shares

-   Tyra Biosciences director Rehan Verjee disclosed an open-market purchase of 971 shares of common stock. \* Shares were bought at a weighted average price of $20.58. \* Verjee’s direct holding rose to 971 shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tyra Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-389333), on September 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [TYRA.US](https://longbridge.com/en/quote/TYRA.US.md)

## Related News & Research

- [Tyra Bioscience Director Makes Bold Insider Move That Could Signal Big Things Ahead](https://longbridge.com/en/news/298782816.md)
- [Tyra Biosciences reports 79% response rate in Phase 2 bladder cancer study of dabogratinib at 60 mg dose](https://longbridge.com/en/news/298445177.md)
- [Micron's Monster Rally Faces Reality Check: China, Bearish Bets and AI Jitters](https://longbridge.com/en/news/301690300.md)
- [Microsoft hits a big milestone that solidifies its revival](https://longbridge.com/en/news/301623691.md)
- [Should You Buy Sandisk Stock Before Oct. 29?](https://longbridge.com/en/news/301741587.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**